High Yield Markets
  • World News
  • Politics
  • Investing
  • Stock
  • Editor’s Pick
Editor's PickInvesting

Pharmaceutical Pricing Around the World

by May 14, 2025
May 14, 2025

Peter Van Doren

Medicine Pharmacy

President Donald Trump recently issued an executive order about pharmaceutical prices. My colleague Michael Cannon has already written that the Department of Health and Human Services “does not have the power to ‘impose’ price controls on private pharmaceutical purchases.”

The order also instructed federal agencies to investigate why European countries pay lower prices for drugs. Why do drug prices vary across countries? An article in the Fall 2024 issue of Regulation offers some insight from economists.

The knowledge embodied in pharmaceuticals is a global public good. The incentives are for all countries to avoid the fixed costs of drug development and clinical trials and pay only the marginal costs of producing a drug. The demand for health care increases with income and population, so the worst-case possibility is that the richest and largest country (i.e., the US) pays all the fixed costs of drug development, and all other countries free ride and pay only the marginal costs.

The authors gathered data on sales revenue and compared the revenue to estimates of marginal cost to calculate each country’s contribution to the fixed costs of drug development. They conclude that a country’s GDP explains 83 percent of the variation in contributions across countries, and the effect of income is greater than proportional. A country with a 100 percent higher GDP contributes 129 percent more to pharmaceutical R&D. So, the US does contribute disproportionately to drug development costs. The rest of the world’s contribution is not zero but is less than would be predicted by income and population alone.

The authors conclude: “Our findings indicate prospective gains from international cooperation–from formal or informal international agreements among high-income countries. If other wealthy countries agreed to contribute more to the global public good, they, and the world, would benefit.”

previous post
EPA Chief Lee Zeldin to Get Rid of Car Feature ‘Everyone Hates’
next post
HHS Secretary RFK Jr. Wrecks Democrat Rep. Josh Harder on Medicaid: “I Don’t Know if You Understand This or Whether You’re Just Mouthing the Democratic Talking Points”

You may also like

Can the White House Denaturalize Domestic Opponents?

July 25, 2025

An Updated Interview with George Selgin on Free...

July 25, 2025

Inflation Can Increase Capital Gains Tax Rate to...

July 25, 2025

Friday Feature: Edefy, “Pod Schooling Made Simple”

July 25, 2025

Yiwu: China’s Free-Market City

July 25, 2025

Man Admits to Medicaid Fraud—That’s Not the Worst...

July 25, 2025

States Are Streamlining Licensing—ICE Is Kicking In Windows

July 24, 2025

Learning from the Caribbean CBDC Experience

July 24, 2025

Fifteen Years of Dodd-Frank: A Legacy of Missed...

July 23, 2025

July 30 Event: Senators Tim Kaine and Rand...

July 23, 2025
Join The Exclusive Subscription Today And Get Premium Articles For Free


Your information is secure and your privacy is protected. By opting in you agree to receive emails from us. Remember that you can opt-out any time, we hate spam too!

Recent Posts

  • Can the White House Denaturalize Domestic Opponents?

    July 25, 2025
  • An Updated Interview with George Selgin on Free Banking and Bitcoin

    July 25, 2025
  • Inflation Can Increase Capital Gains Tax Rate to Infinity

    July 25, 2025
  • Friday Feature: Edefy, “Pod Schooling Made Simple”

    July 25, 2025
  • Yiwu: China’s Free-Market City

    July 25, 2025
  • About Us
  • Contacts
  • Privacy Policy
  • Terms and Conditions
  • Email Whitelisting

Copyright © 2025 highyieldmarkets.com | All Rights Reserved

High Yield Markets
  • World News
  • Politics
  • Investing
  • Stock
  • Editor’s Pick